Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Alcohol-induced changes in the gut microbiome and metabolome of rhesus macaques.

Zhang X, Yasuda K, Gilmore RA, Westmoreland SV, Platt DM, Miller GM, Vallender EJ.

Psychopharmacology (Berl). 2019 May;236(5):1531-1544. doi: 10.1007/s00213-019-05217-z. Epub 2019 Mar 22.

PMID:
30903211
2.

GABAA Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric Modulators.

Berro LF, Rüedi-Bettschen D, Cook JE, Golani LK, Li G, Jahan R, Rashid F, Cook JM, Rowlett JK, Platt DM.

Alcohol Clin Exp Res. 2019 May;43(5):791-802. doi: 10.1111/acer.14000. Epub 2019 Apr 8.

PMID:
30861153
3.

Correction to: GABAA Receptor Subtype Mechanisms and the Abuse-Related Effects of Ethanol: Genetic and Pharmacological Evidence.

Chandler CM, Overton JS, Rüedi-Bettschen D, Platt DM.

Handb Exp Pharmacol. 2018;248:615. doi: 10.1007/164_2018_190.

PMID:
30810860
4.

α5GABAA subunit-containing receptors and sweetened alcohol cue-induced reinstatement and active sweetened alcohol self-administration in male rats.

Chandler CM, Reeves-Darby J, Jones SA, McDonald JA, Li G, Rahman MT, Cook JM, Platt DM.

Psychopharmacology (Berl). 2019 Jun;236(6):1797-1806. doi: 10.1007/s00213-018-5163-6. Epub 2019 Jan 12.

PMID:
30637435
5.

Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys.

Duke AN, Meng Z, Platt DM, Atack JR, Dawson GR, Reynolds DS, Tiruveedhula VVNPB, Li G, Stephen MR, Sieghart W, Cook JM, Rowlett JK.

J Pharmacol Exp Ther. 2018 Jul;366(1):145-157. doi: 10.1124/jpet.118.249250. Epub 2018 May 2.

6.

GABAA Receptor Subtype Mechanisms and the Abuse-Related Effects of Ethanol: Genetic and Pharmacological Evidence.

Chandler CM, Overton JS, Rüedi-Bettschen D, Platt DM.

Handb Exp Pharmacol. 2018;248:3-27. doi: 10.1007/164_2017_80. Erratum in: Handb Exp Pharmacol. 2018;248:615.

PMID:
29204713
7.

Persistent negative effects of alcohol drinking on aspects of novelty-directed behavior in male rhesus macaques.

Chandler CM, Follett ME, Porter NJ, Liang KY, Vallender EJ, Miller GM, Rowlett JK, Platt DM.

Alcohol. 2017 Sep;63:19-26. doi: 10.1016/j.alcohol.2017.03.002. Epub 2017 Jun 23.

8.

Detrimental effects of self-administered methamphetamine during pregnancy on offspring development in the rat.

Rüedi-Bettschen D, Platt DM.

Drug Alcohol Depend. 2017 Aug 1;177:171-177. doi: 10.1016/j.drugalcdep.2017.03.042. Epub 2017 Jun 1.

9.

Reinforcing effectiveness of midazolam, ethanol, and sucrose: behavioral economic comparison of a mixture relative to its component solutions.

Townsend EA, Platt DM, Rowlett JK, Roma PG, Freeman KB.

Behav Pharmacol. 2017 Aug;28(5):386-393. doi: 10.1097/FBP.0000000000000308.

10.

Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.

Heresi GA, Platt DM, Wang W, Divers CH, Joish VN, Teal SA, Yu JS.

BMC Pulm Med. 2017 Apr 11;17(1):58. doi: 10.1186/s12890-017-0399-1.

11.

Convergent Balancing Selection on the Mu-Opioid Receptor in Primates.

Sweeney CG, Rando JM, Panas HN, Miller GM, Platt DM, Vallender EJ.

Mol Biol Evol. 2017 Jul 1;34(7):1629-1643. doi: 10.1093/molbev/msx105.

12.

Benzodiazepine and neuroactive steroid combinations in rats: anxiolytic-like and discriminative stimulus effects.

Gunter BW, Jones SA, Paul IA, Platt DM, Rowlett JK.

Psychopharmacology (Berl). 2016 Sep;233(17):3237-47. doi: 10.1007/s00213-016-4369-8. Epub 2016 Jun 29.

13.

Efficient Multiplexed Integration of Synergistic Alleles and Metabolic Pathways in Yeasts via CRISPR-Cas.

Horwitz AA, Walter JM, Schubert MG, Kung SH, Hawkins K, Platt DM, Hernday AD, Mahatdejkul-Meadows T, Szeto W, Chandran SS, Newman JD.

Cell Syst. 2015 Jul 29;1(1):88-96. doi: 10.1016/j.cels.2015.02.001. Epub 2015 Mar 12.

14.

Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study.

Tapson VF, Platt DM, Xia F, Teal SA, de la Orden M, Divers CH, Satler CA, Joish VN, Channick RN.

Am J Med. 2016 Sep;129(9):978-985.e2. doi: 10.1016/j.amjmed.2016.03.006. Epub 2016 Apr 1.

PMID:
27046247
15.

Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis.

Fischer BD, Platt DM, Rallapalli SK, Namjoshi OA, Cook JM, Rowlett JK.

Drug Alcohol Depend. 2016 Jan 1;158:22-9. doi: 10.1016/j.drugalcdep.2015.10.026. Epub 2015 Oct 30.

16.

Differential interactions engendered by benzodiazepine and neuroactive steroid combinations on schedule-controlled responding in rats.

Gunter BW, Platt DM, Rowlett JK.

Pharmacol Biochem Behav. 2015 Oct;137:53-9. doi: 10.1016/j.pbb.2015.08.003. Epub 2015 Aug 6.

17.

Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors.

Rüedi-Bettschen D, Spealman RD, Platt DM.

Psychopharmacology (Berl). 2015 Aug;232(16):2959-68. doi: 10.1007/s00213-015-3932-z. Epub 2015 Apr 17.

18.

The importance of animals in advancing research on alcohol use disorders.

Helms CM, Bell RL, Bennett AJ, Davies DL, Chester JA, Kosten TA, Leeman RF, Panicker S, Platt DM, Weiner JL, Edwards S.

Alcohol Clin Exp Res. 2015 Apr;39(4):575-8. doi: 10.1111/acer.12668. No abstract available.

19.

Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.

Zhang J, Saur T, Duke AN, Grant SG, Platt DM, Rowlett JK, Isacson O, Yao WD.

J Neurogenet. 2014 Mar-Jun;28(1-2):98-111. doi: 10.3109/01677063.2014.892486. Epub 2014 Apr 22.

20.

Little evidence of a role for the α1GABAA subunit-containing receptor in a rhesus monkey model of alcohol drinking.

Sawyer EK, Moran C, Sirbu MH, Szafir M, Van Linn M, Namjoshi O, Phani Babu Tiruveedhula VV, Cook JM, Platt DM.

Alcohol Clin Exp Res. 2014 Apr;38(4):1108-17. doi: 10.1111/acer.12320. Epub 2013 Dec 13.

21.

Trace amine associated receptor 1 modulates behavioral effects of ethanol.

Lynch LJ, Sullivan KA, Vallender EJ, Rowlett JK, Platt DM, Miller GM.

Subst Abuse. 2013 Jun 4;7:117-26. doi: 10.4137/SART.S12110. Print 2013.

22.

Reinforcing effects of compounds lacking intrinsic efficacy at α1 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys.

Shinday NM, Sawyer EK, Fischer BD, Platt DM, Licata SC, Atack JR, Dawson GR, Reynolds DS, Rowlett JK.

Neuropsychopharmacology. 2013 May;38(6):1006-14. doi: 10.1038/npp.2012.265. Epub 2012 Dec 27.

23.

Modulation of α5 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys.

Rüedi-Bettschen D, Rowlett JK, Rallapalli S, Clayton T, Cook JM, Platt DM.

Alcohol Clin Exp Res. 2013 Apr;37(4):624-34. doi: 10.1111/acer.12018. Epub 2012 Nov 5.

24.

Glycine transporter-1 inhibition preceding extinction training inhibits reacquisition of cocaine seeking.

Achat-Mendes C, Nic Dhonnchadha BÁ, Platt DM, Kantak KM, Spealman RD.

Neuropsychopharmacology. 2012 Dec;37(13):2837-45. doi: 10.1038/npp.2012.155. Epub 2012 Sep 5.

25.

Antagonism of metabotropic glutamate 1 receptors attenuates behavioral effects of cocaine and methamphetamine in squirrel monkeys.

Achat-Mendes C, Platt DM, Spealman RD.

J Pharmacol Exp Ther. 2012 Oct;343(1):214-24. doi: 10.1124/jpet.112.196295. Epub 2012 Jul 18.

26.

Models of neurological disease (substance abuse): self-administration in monkeys.

Platt DM, Carey G, Spealman RD.

Curr Protoc Pharmacol. 2011 Dec;Chapter 10:Unit10.5. doi: 10.1002/0471141755.ph1005s56.

27.

Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys.

Fischer BD, Atack JR, Platt DM, Reynolds DS, Dawson GR, Rowlett JK.

Psychopharmacology (Berl). 2011 May;215(2):311-9. doi: 10.1007/s00213-010-2142-y. Epub 2010 Dec 30.

28.

Opioid receptors and the discriminative stimulus effects of ethanol in squirrel monkeys: Mu and delta opioid receptor mechanisms.

Platt DM, Bano KM.

Eur J Pharmacol. 2011 Jan 10;650(1):233-9. doi: 10.1016/j.ejphar.2010.09.064. Epub 2010 Oct 15.

29.

Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.

Yin W, Majumder S, Clayton T, Petrou S, VanLinn ML, Namjoshi OA, Ma C, Cromer BA, Roth BL, Platt DM, Cook JM.

Bioorg Med Chem. 2010 Nov 1;18(21):7548-64. doi: 10.1016/j.bmc.2010.08.049. Epub 2010 Sep 29.

30.

Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys.

Achat-Mendes C, Grundt P, Cao J, Platt DM, Newman AH, Spealman RD.

J Pharmacol Exp Ther. 2010 Aug;334(2):556-65. doi: 10.1124/jpet.110.167619. Epub 2010 May 21.

31.

A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeys.

Vallender EJ, Rüedi-Bettschen D, Miller GM, Platt DM.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):252-6. doi: 10.1016/j.drugalcdep.2010.01.005. Epub 2010 Feb 13.

32.

Asymmetric generalization and interaction profiles in rhesus monkeys discriminating intravenous cocaine or intravenous heroin from vehicle.

Platt DM, Rowlett JK, Spealman RD.

J Pharmacol Exp Ther. 2010 Mar;332(3):985-95. doi: 10.1124/jpet.109.162941. Epub 2009 Dec 4.

33.

Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms.

Rüedi-Bettschen D, Rowlett JK, Spealman RD, Platt DM.

Psychopharmacology (Berl). 2010 Jun;210(2):169-77. doi: 10.1007/s00213-009-1705-2. Epub 2009 Oct 27.

34.

Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.

Licata SC, Platt DM, Rüedi-Bettschen D, Atack JR, Dawson GR, Van Linn ML, Cook JM, Rowlett JK.

Neuropharmacology. 2010 Feb;58(2):357-64. doi: 10.1016/j.neuropharm.2009.10.004. Epub 2009 Oct 22.

35.

D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning.

Nic Dhonnchadha BA, Szalay JJ, Achat-Mendes C, Platt DM, Otto MW, Spealman RD, Kantak KM.

Neuropsychopharmacology. 2010 Jan;35(2):357-67. doi: 10.1038/npp.2009.139.

36.

The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.

Achat-Mendes C, Platt DM, Newman AH, Spealman RD.

Psychopharmacology (Berl). 2009 Sep;206(1):73-84. doi: 10.1007/s00213-009-1581-9. Epub 2009 Jun 10.

37.

Deciding in the dark: advance directives and continuation of treatment in chronic critical illness.

Camhi SL, Mercado AF, Morrison RS, Du Q, Platt DM, August GI, Nelson JE.

Crit Care Med. 2009 Mar;37(3):919-25. doi: 10.1097/CCM.0b013e31819613ce.

38.

Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.

Achat-Mendes C, Valdez GR, Platt DM, Rowlett JK, Spealman RD.

Psychopharmacology (Berl). 2009 Jun;204(3):489-98. doi: 10.1007/s00213-009-1480-0. Epub 2009 Feb 19.

39.

Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys.

Licata SC, Platt DM, Cook JM, Van Linn ML, Rowlett JK.

Psychopharmacology (Berl). 2009 Apr;203(3):539-46. doi: 10.1007/s00213-008-1401-7. Epub 2008 Nov 25.

40.

Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine.

Platt DM, Rowlett JK, Spealman RD.

Psychopharmacology (Berl). 2008 Oct;200(2):167-76. doi: 10.1007/s00213-008-1191-y. Epub 2008 May 29.

41.

Intravenous self-administration techniques in monkeys.

Platt DM, Carey G, Spealman RD.

Curr Protoc Neurosci. 2005 Aug;Chapter 9:Unit 9.21. doi: 10.1002/0471142301.ns0921s32.

PMID:
18428630
42.

Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms.

Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, Spealman RD.

J Pharmacol Exp Ther. 2007 Nov;323(2):525-33. Epub 2007 Aug 16.

PMID:
17702903
43.

Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys.

Platt DM, Rowlett JK, Spealman RD.

J Pharmacol Exp Ther. 2007 Aug;322(2):894-902. Epub 2007 May 15.

PMID:
17505018
44.

Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.

Rowlett JK, Platt DM, Yao WD, Spealman RD.

J Pharmacol Exp Ther. 2007 Jun;321(3):1135-43. Epub 2007 Mar 9.

PMID:
17351103
45.

Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes.

Duke AN, Platt DM, Cook JM, Huang S, Yin W, Mattingly BA, Rowlett JK.

Psychopharmacology (Berl). 2006 Aug;187(3):321-30. Epub 2006 Jun 17.

PMID:
16783540
46.
47.

Understanding how the brain perceives alcohol: neurobiological basis of ethanol discrimination.

Hodge CW, Grant KA, Becker HC, Besheer J, Crissman AM, Platt DM, Shannon EE, Shelton KL.

Alcohol Clin Exp Res. 2006 Feb;30(2):203-13.

PMID:
16441269
49.

Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys.

Platt DM, Duggan A, Spealman RD, Cook JM, Li X, Yin W, Rowlett JK.

J Pharmacol Exp Ther. 2005 May;313(2):658-67. Epub 2005 Jan 13.

PMID:
15650112
50.

Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR.

Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):915-20. Epub 2005 Jan 11.

Supplemental Content

Loading ...
Support Center